Evidence map›Paper›PMID 25203313›Full record

ArticlePloS one2014

Magnetic resonance imaging and spectroscopy assessment of lower extremity skeletal muscles in boys with Duchenne muscular dystrophy: a multicenter cross sectional study.

Sean C Forbes, Rebecca J Willcocks, William T Triplett, William D Rooney, Donovan J Lott, Dah-Jyuu Wang, Jim Pollaro, Claudia R Senesac, Michael J Daniels, Richard S Finkel and 7 more

Erratum issued 2 registry-linked trialsOpen access · goldAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 66 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01484678 recruitingnot on this mapstarted 2020, after this paper: background citation

Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy

TypeobservationalSponsorUniversity of FloridaRan2020 to 2026Enrolled550ConditionsDuchenne Muscular Dystrophy, Becker Muscular Dystrophy
NCT06290713 phase2recruitingnot on this mapstarted 2024, after this paper: background citation

Vasodilators and Exercise as Adjuvant Therapy for Duchenne Muscular Dystrophy (VASO-REx Study)

TypeinterventionalSponsorUniversity of FloridaRan2024 to 2026Enrolled50ConditionsDuchenne Muscular Dystrophy, Duchenne Disease, Muscular Dystrophy, Muscular Dystrophy in ChildrenArmsTadalafil, Placebo, Exercise Training
3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 1 synthesis or guideline pooled it, 120 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Sean C ForbesDepartment of Physical Therapy, University of Florida, Gainesville, FL, United States of America.
Rebecca J WillcocksDepartment of Physical Therapy, University of Florida, Gainesville, FL, United States of America.
William T TriplettDepartment of Physical Therapy, University of Florida, Gainesville, FL, United States of America.
William D RooneyOregon Health & Science University, Portland, OR, United States of America.
Donovan J LottDepartment of Physical Therapy, University of Florida, Gainesville, FL, United States of America.
Dah-Jyuu WangThe Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
Jim PollaroOregon Health & Science University, Portland, OR, United States of America.
Claudia R SenesacDepartment of Physical Therapy, University of Florida, Gainesville, FL, United States of America.
Michael J DanielsDepartment of Statistics & Data Sciences and Department of Integrative Biology, the University of Texas at Austin, Austin, TX, United States of America.
Richard S FinkelThe Children's Hospital of Philadelphia, Philadelphia, PA, United States of America; Nemours Children's Hospital, Orlando, Florida, United States of America.
Barry S RussmanOregon Health & Science University, Portland, OR, United States of America.
Barry J ByrneDepartment of Pediatrics and Molecular Genetics & Microbiology, Powell Gene Therapy Center, University of Florida, Gainesville, FL, United States of America.
Erika L FinangerOregon Health & Science University, Portland, OR, United States of America.
Gihan I TennekoonThe Children's Hospital of Philadelphia, Philadelphia, PA, United States of America.
Glenn A WalterDepartment of Physiology and Functional Genomics, University of Florida, Gainesville, FL, United States of America.
H Lee SweeneyDepartment of Physiology, University of Pennsylvania, Philadelphia, PA, United States of America.
Krista VandenborneDepartment of Physical Therapy, University of Florida, Gainesville, FL, United States of America.
University of Florida · USOregon Health & Science University · USChildren's Hospital of Philadelphia · USThe University of Texas at Austin · USUniversity of Pennsylvania · US

Funding

Training and education CoreU54AR052646 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI MCNALLY, ELIZABETH M, SWEENEY, H LEE · 2005 to 2020
$24.1M
Magnetic Resonance Imaging and Biomarkers for Muscular DystropyR01AR056973 · NIAMS · UNIVERSITY OF FLORIDA · PI VANDENBORNE, KRISTA H · 2010 to 2024
$20.2M
The Relationship between Genomic Variants and MRI/MRS Markers in DMDR01AR065943 · NIAMS · UNIVERSITY OF FLORIDA · PI WALTER, GLENN · 2013 to 2015
$998k
NIAMS NIH HHS 1U54AR052646NIAMS NIH HHS R01 AR056973NIAMS NIH HHS R01AR056973NIAMS NIH HHS R01 AR065943NIAMS NIH HHS R01AR065943NIAMS NIH HHS U54 AR052646
6 · The paper itself

Abstract

introductionDuchenne muscular dystrophy (DMD) is an X-linked recessive disorder that results in functional deficits. However, these functional declines are often not able to be quantified in clinical trials for DMD until after age 7. In this study, we hypothesized that (1)H2O T2 derived using (1)H-MRS and MRI-T2 will be sensitive to muscle involvement at a young age (5-7 years) consistent with increased inflammation and muscle damage in a large cohort of DMD subjects compared to controls.

methodsMR data were acquired from 123 boys with DMD (ages 5-14 years; mean 8.6 SD 2.2 years) and 31 healthy controls (age 9.7 SD 2.3 years) using 3-Tesla MRI instruments at three institutions (University of Florida, Oregon Health & Science University, and Children's Hospital of Philadelphia). T2-weighted multi-slice spin echo (SE) axial images and single voxel 1H-MRS were acquired from the lower leg and thigh to measure lipid fraction and (1)H2O T2.

resultsMRI-T2, (1)H2O T2, and lipid fraction were greater (p<0.05) in DMD compared to controls. In the youngest age group, DMD values were different (p<0.05) than controls for the soleus MRI-T2, (1)H2O T2 and lipid fraction and vastus lateralis MRI-T2 and (1)H2O T2. In the boys with DMD, MRI-T2 and lipid fraction were greater (p<0.05) in the oldest age group (11-14 years) than the youngest age group (5-6.9 years), while 1H2O T2 was lower in the oldest age group compared to the young age group. DISCUSSION: Overall, MR measures of T2 and lipid fraction revealed differences between DMD and Controls. Furthermore, MRI-T2 was greater in the older age group compared to the young age group, which was associated with higher lipid fractions. Overall, MR measures of T2 and lipid fraction show excellent sensitivity to DMD disease pathologies and potential therapeutic interventions in DMD, even in the younger boys.

Indexed as

LegMagnetic Resonance ImagingAdolescentAge DistributionCase-Control StudiesChildChild, PreschoolCohort StudiesCross-Sectional StudiesDisease ProgressionHumansLipid MetabolismMaleMuscle, SkeletalMuscular Dystrophy, Duchenne

Identifiers

PMID25203313
PMCPMC4159278
OpenAlexW2050441916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.